Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 170 articles:
HTML format
Text format



Single Articles


    January 2017
  1. BINENBAUM Y, Ben-David G, Gil Z, Slutsker YZ, et al
    Cold Atmospheric Plasma, Created at the Tip of an Elongated Flexible Capillary Using Low Electric Current, Can Slow the Progression of Melanoma.
    PLoS One. 2017;12:e0169457.
    PubMed     Text format     Abstract available


  2. WANG JJ, Wu CC, Lee CL, Hsieh SL, et al
    Antimelanogenic, Antioxidant and Antiproliferative Effects of Antrodia camphorata Fruiting Bodies on B16-F0 Melanoma Cells.
    PLoS One. 2017;12:e0170924.
    PubMed     Text format     Abstract available


  3. ZAINULABADEEN A, Yao P, Zare H
    Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma.
    PLoS One. 2017;12:e0170025.
    PubMed     Text format     Abstract available


  4. NIKOLOVSKA K, Spillmann D, Haier J, Ladanyi A, et al
    Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase.
    PLoS One. 2017;12:e0170054.
    PubMed     Text format     Abstract available


  5. LABERGE GS, Duvall E, Grasmick Z, Haedicke K, et al
    A Melanoma Lymph Node Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: A Second Case of Leucocyte-Tumor Cell Hybridization in Cancer Metastasis.
    PLoS One. 2017;12:e0168581.
    PubMed     Text format     Abstract available


  6. KONSTANTAKOU EG, Velentzas AD, Anagnostopoulos AK, Litou ZI, et al
    Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets.
    PLoS One. 2017;12:e0171512.
    PubMed     Text format     Abstract available


  7. SHAO C, Dai W, Li H, Tang W, et al
    The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics.
    PLoS One. 2017;12:e0171676.
    PubMed     Text format     Abstract available


  8. BAZIN M, Purohit NK, Shah GM
    Comprehensive measurement of UVB-induced non-melanoma skin cancer burden in mice using photographic images as a substitute for the caliper method.
    PLoS One. 2017;12:e0171875.
    PubMed     Text format     Abstract available


  9. XU G, Xue Y, Ozkurt ZG, Slimani N, et al
    Photoacoustic imaging features of intraocular tumors: Retinoblastoma and uveal melanoma.
    PLoS One. 2017;12:e0170752.
    PubMed     Text format     Abstract available


  10. WANG S, Fan W, Wan B, Tu M, et al
    Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
    PLoS One. 2017;12:e0172498.
    PubMed     Text format     Abstract available


  11. SCHMIDT SA, Ording AG, Horvath-Puho E, Sorensen HT, et al
    Non-melanoma skin cancer and risk of Alzheimer's disease and all-cause dementia.
    PLoS One. 2017;12:e0171527.
    PubMed     Text format     Abstract available


  12. ECHTLER K, Konrad I, Lorenz M, Schneider S, et al
    Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.
    PLoS One. 2017;12:e0172788.
    PubMed     Text format     Abstract available


  13. TUDOR D, Nenu I, Filip GA, Olteanu D, et al
    Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacy.
    PLoS One. 2017;12:e0173241.
    PubMed     Text format     Abstract available



  14. Correction: Comprehensive measurement of UVB-induced non-melanoma skin cancer burden in mice using photographic images as a substitute for the caliper method.
    PLoS One. 2017;12:e0173718.
    PubMed     Text format     Abstract available


  15. WESSELS D, Lusche DF, Voss E, Kuhl S, et al
    Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.
    PLoS One. 2017;12:e0173400.
    PubMed     Text format     Abstract available


  16. LUO L, Orlow I, Kanetsky PA, Thomas NE, et al
    No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival.
    PLoS One. 2017;12:e0174234.
    PubMed     Text format     Abstract available


  17. DEINLEIN T, Arzberger E, Zalaudek I, Massone C, et al
    Dermoscopic characteristics of melanoma according to the criteria "ulceration" and "mitotic rate" of the AJCC 2009 staging system for melanoma.
    PLoS One. 2017;12:e0174871.
    PubMed     Text format     Abstract available


  18. HAN X, Han Y, Zheng Y, Sun Q, et al
    Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivo.
    PLoS One. 2017;12:e0175950.
    PubMed     Text format     Abstract available


  19. RITSMA L, Dey-Guha I, Talele N, Sole X, et al
    Integrin beta1 activation induces an anti-melanoma host response.
    PLoS One. 2017;12:e0175300.
    PubMed     Text format     Abstract available


  20. LEE BH, Neela PH, Kent MS, Zehnder AM, et al
    IQGAP1 is an oncogenic target in canine melanoma.
    PLoS One. 2017;12:e0176370.
    PubMed     Text format     Abstract available


  21. WELINDER C, Pawlowski K, Szasz AM, Yakovleva M, et al
    Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
    PLoS One. 2017;12:e0176167.
    PubMed     Text format     Abstract available


  22. SHEEN YS, Liao YH, Lin MH, Chen JS, et al
    Clinicopathological features and prognosis of patients with de novo versus nevus-associated melanoma in Taiwan.
    PLoS One. 2017;12:e0177126.
    PubMed     Text format     Abstract available


  23. HARTUNG N, Huynh CT, Gaudy-Marqueste C, Flavian A, et al
    Study of metastatic kinetics in metastatic melanoma treated with B-RAF inhibitors: Introducing mathematical modelling of kinetics into the therapeutic decision.
    PLoS One. 2017;12:e0176080.
    PubMed     Text format     Abstract available


  24. KEE JY, Han YH, Kim DS, Mun JG, et al
    beta-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway.
    PLoS One. 2017;12:e0176937.
    PubMed     Text format     Abstract available


  25. NOGUCHI K, Dalton AC, Howley BV, McCall BJ, et al
    Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    PLoS One. 2017;12:e0177830.
    PubMed     Text format     Abstract available


  26. WU KJ, Huang JM, Zhong HJ, Dong ZZ, et al
    A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells.
    PLoS One. 2017;12:e0177123.
    PubMed     Text format     Abstract available


  27. JOHNSON CP, Kim IK, Esmaeli B, Amin-Mansour A, et al
    Systematic genomic and translational efficiency studies of uveal melanoma.
    PLoS One. 2017;12:e0178189.
    PubMed     Text format     Abstract available


  28. POPULO H, Batista R, Sampaio C, Pardal J, et al
    SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma.
    PLoS One. 2017;12:e0180392.
    PubMed     Text format     Abstract available


  29. URVANEGIA AC, Tavoloni Braga JC, Shitara D, Fregnani JH, et al
    Reflectance confocal microscopy features of BRAF V600E mutated thin melanomas detected by immunohistochemistry.
    PLoS One. 2017;12:e0179745.
    PubMed     Text format     Abstract available


  30. TRUCCO LD, Roselli E, Araya P, Nunez NG, et al
    Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma.
    PLoS One. 2017;12:e0179897.
    PubMed     Text format     Abstract available


  31. WANG S, Fan W, Wan B, Tu M, et al
    Correction: Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
    PLoS One. 2017;12:e0181129.
    PubMed     Text format     Abstract available


  32. PAYR S, Tichy B, Atteneder C, Michel M, et al
    Redifferentiation of aged human articular chondrocytes by combining bone morphogenetic protein-2 and melanoma inhibitory activity protein in 3D-culture.
    PLoS One. 2017;12:e0179729.
    PubMed     Text format     Abstract available


  33. CHEN J, Peng C, Lei L, Zhang J, et al
    Nuclear envelope-distributed CD147 interacts with and inhibits the transcriptional function of RING1 and promotes melanoma cell motility.
    PLoS One. 2017;12:e0183689.
    PubMed     Text format     Abstract available


  34. ZALESNA I, Osrodek M, Hartman ML, Rozanski M, et al
    Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of V600EBRAF melanoma cells and their response to vemurafenib and trametinib in vitro.
    PLoS One. 2017;12:e0183498.
    PubMed     Text format     Abstract available


  35. ZHAO X, Kong F, Wang L, Zhang H, et al
    c-FLIP and the NOXA/Mcl-1 axis participate in the synergistic effect of pemetrexed plus cisplatin in human choroidal melanoma cells.
    PLoS One. 2017;12:e0184135.
    PubMed     Text format     Abstract available


  36. TARMANN L, Wackernagel W, Ivastinovic D, Schneider M, et al
    Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
    PLoS One. 2017;12:e0183833.
    PubMed     Text format     Abstract available


  37. KIM HS, Shin MS, Cheon MS, Kim JW, et al
    GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas.
    PLoS One. 2017;12:e0174565.
    PubMed     Text format     Abstract available


  38. NOBEYAMA Y, Nakagawa H
    Silencing of interferon regulatory factor gene 6 in melanoma.
    PLoS One. 2017;12:e0184444.
    PubMed     Text format     Abstract available


  39. MASUDA Y, Nakayama Y, Tanaka A, Naito K, et al
    Antitumor activity of orally administered maitake alpha-glucan by stimulating antitumor immune response in murine tumor.
    PLoS One. 2017;12:e0173621.
    PubMed     Text format     Abstract available


  40. ZHA L, He L, Xie W, Cheng J, et al
    Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.
    PLoS One. 2017;12:e0177964.
    PubMed     Text format     Abstract available


  41. GILMORE S
    Melanoma screening: Informing public health policy with quantitative modelling.
    PLoS One. 2017;12:e0182349.
    PubMed     Text format     Abstract available


  42. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Text format     Abstract available


  43. HULUR I, Skol AD, Gamazon ER, Cox NJ, et al
    Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma.
    PLoS One. 2017;12:e0185730.
    PubMed     Text format     Abstract available


  44. BRASTER R, Grewal S, Visser R, Einarsdottir HK, et al
    Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.
    PLoS One. 2017;12:e0177736.
    PubMed     Text format     Abstract available


  45. JASINSKA-KONIOR K, Pochylczuk K, Czajka E, Michalik M, et al
    Proton beam irradiation inhibits the migration of melanoma cells.
    PLoS One. 2017;12:e0186002.
    PubMed     Text format     Abstract available


  46. TERMINI JM, Gupta S, Raffa FN, Guirado E, et al
    Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion.
    PLoS One. 2017;12:e0184915.
    PubMed     Text format     Abstract available


  47. NAKAMURA S, Kunikata T, Matsumoto Y, Hanaya T, et al
    Effects of a non-cyclodextrin cyclic carbohydrate on mouse melanoma cells: Characterization of a new type of hypopigmenting sugar.
    PLoS One. 2017;12:e0186640.
    PubMed     Text format     Abstract available


  48. MCWHIRTER SR, Duffy DL, Lee KJ, Wimberley G, et al
    Classifying dermoscopic patterns of naevi in a case-control study of melanoma.
    PLoS One. 2017;12:e0186647.
    PubMed     Text format     Abstract available


  49. VALIANATOS G, Valcikova B, Growkova K, Verlande A, et al
    A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PLoS One. 2017;12:e0185801.
    PubMed     Text format     Abstract available


  50. CHEN LL, Zhu J, Schumacher J, Wei C, et al
    SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.
    PLoS One. 2017;12:e0184154.
    PubMed     Text format     Abstract available


  51. VANDEREYKEN M, Jacques S, Van Overmeire E, Amand M, et al
    Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner.
    PLoS One. 2017;12:e0185786.
    PubMed     Text format     Abstract available


  52. ZHENG X, Tang H, Zhao X, Sun Y, et al
    Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p.
    PLoS One. 2017;12:e0184746.
    PubMed     Text format     Abstract available


  53. TIWARY S, Xu L
    Correction: FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells.
    PLoS One. 2017;12:e0187388.
    PubMed     Text format     Abstract available


  54. PEREZ EC, Xander P, Laurindo MFL, Novaes E Brito RR, et al
    The axis IL-10/claudin-10 is implicated in the modulation of aggressiveness of melanoma cells by B-1 lymphocytes.
    PLoS One. 2017;12:e0187333.
    PubMed     Text format     Abstract available


  55. GAISER MR, Skorokhod A, Gransheier D, Weide B, et al
    Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma.
    PLoS One. 2017;12:e0188602.
    PubMed     Text format     Abstract available


  56. GURAN R, Vanickova L, Horak V, Krizkova S, et al
    MALDI MSI of MeLiM melanoma: Searching for differences in protein profiles.
    PLoS One. 2017;12:e0189305.
    PubMed     Text format     Abstract available


    January 2016
  57. HEISE R, Amann PM, Ensslen S, Marquardt Y, et al
    Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.
    PLoS One. 2016;11:e0146325.
    PubMed     Text format     Abstract available


  58. MEHTA K, Appleman L, Wang H, Tarhini AA, et al
    Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients.
    PLoS One. 2016;11:e0147153.
    PubMed     Text format     Abstract available


  59. SHEEN YS, Liao YH, Lin MH, Chiu HC, et al
    Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
    PLoS One. 2016;11:e0147431.
    PubMed     Text format     Abstract available


  60. LIU J, Shen B, Shi M, Cai J, et al
    Higher Caffeinated Coffee Intake Is Associated with Reduced Malignant Melanoma Risk: A Meta-Analysis Study.
    PLoS One. 2016;11:e0147056.
    PubMed     Text format     Abstract available


  61. VENKATESAN N, Kanwar J, Deepa PR, Khetan V, et al
    Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
    PLoS One. 2016;11:e0146128.
    PubMed     Text format     Abstract available


  62. TIWARY S, Xu L
    FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells.
    PLoS One. 2016;11:e0147638.
    PubMed     Text format     Abstract available


  63. FAN L, Li H, Niu Y, Chen Q, et al
    Characterization and Inducing Melanoma Cell Apoptosis Activity of Mannosylerythritol Lipids-A Produced from Pseudozyma aphidis.
    PLoS One. 2016;11:e0148198.
    PubMed     Text format     Abstract available


  64. PICH C, Teiti I, Sarrabayrouse G, Gallardo F, et al
    Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity.
    PLoS One. 2016;11:e0148095.
    PubMed     Text format     Abstract available


  65. DUPRAT JP, Brechtbulh ER, Costa de Sa B, Enokihara M, et al
    Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group.
    PLoS One. 2016;11:e0148160.
    PubMed     Text format     Abstract available


  66. EIKE LM, Mauseth B, Camilio KA, Rekdal O, et al
    The Cytolytic Amphipathic beta(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma.
    PLoS One. 2016;11:e0148980.
    PubMed     Text format     Abstract available


  67. OBA J, Nakahara T, Hashimoto-Hachiya A, Liu M, et al
    CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis.
    PLoS One. 2016;11:e0149285.
    PubMed     Text format     Abstract available


  68. KRYZA D, Debordeaux F, Azema L, Hassan A, et al
    Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas.
    PLoS One. 2016;11:e0149387.
    PubMed     Text format     Abstract available


  69. HURABIELLE C, Pillebout E, Stehle T, Pages C, et al
    Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma.
    PLoS One. 2016;11:e0149873.
    PubMed     Text format     Abstract available


  70. STASIAK M, Boncela J, Perreau C, Karamanou K, et al
    Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity.
    PLoS One. 2016;11:e0150226.
    PubMed     Text format     Abstract available


  71. TOIA F, Buccheri S, Anfosso A, Moschella F, et al
    Skewed Differentiation of Circulating Vgamma9Vdelta2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.
    PLoS One. 2016;11:e0149570.
    PubMed     Text format     Abstract available


  72. NEWMAN JA, Cooper CD, Roos AK, Aitkenhead H, et al
    Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding.
    PLoS One. 2016;11:e0148762.
    PubMed     Text format     Abstract available


  73. KOSZALKA P, Golunska M, Urban A, Stasilojc G, et al
    Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.
    PLoS One. 2016;11:e0151420.
    PubMed     Text format     Abstract available


  74. JOHANSEN P, Andersen JD, Madsen LN, Ullum H, et al
    Pigmentary Markers in Danes - Associations with Quantitative Skin Colour, Nevi Count, Familial Atypical Multiple-Mole, and Melanoma Syndrome.
    PLoS One. 2016;11:e0150381.
    PubMed     Text format     Abstract available


  75. KABILOVA TO, Sen'kova AV, Nikolin VP, Popova NA, et al
    Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice.
    PLoS One. 2016;11:e0150751.
    PubMed     Text format     Abstract available


  76. PAPPALARDO F, Russo G, Candido S, Pennisi M, et al
    Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer.
    PLoS One. 2016;11:e0152104.
    PubMed     Text format     Abstract available


  77. KASAI S, Arakawa N, Okubo A, Shigeeda W, et al
    NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG.
    PLoS One. 2016;11:e0153181.
    PubMed     Text format     Abstract available


  78. GRECKA E, Statkiewicz M, Gorska A, Biernacka M, et al
    Prenyl Ammonium Salts - New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.
    PLoS One. 2016;11:e0153633.
    PubMed     Text format     Abstract available


  79. SATO S, Murakami A, Kuwajima A, Takehara K, et al
    Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
    PLoS One. 2016;11:e0154285.
    PubMed     Text format     Abstract available


  80. HARLE A, Salleron J, Franczak C, Dubois C, et al
    Detection of BRAF Mutations Using a Fully Automated Platform and Comparison with High Resolution Melting, Real-Time Allele Specific Amplification, Immunohistochemistry and Next Generation Sequencing Assays, for Patients with Metastatic Melanoma.
    PLoS One. 2016;11:e0153576.
    PubMed     Text format     Abstract available


  81. BLOKZIJL A, Chen LE, Gustafsdottir SM, Vuu J, et al
    Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
    PLoS One. 2016;11:e0154214.
    PubMed     Text format     Abstract available


  82. SHA J, Gastman BR, Morris N, Mesinkovska NA, et al
    The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons.
    PLoS One. 2016;11:e0154915.
    PubMed     Text format     Abstract available


  83. SCHUSTER C, Akslen LA, Straume O
    Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
    PLoS One. 2016;11:e0155242.
    PubMed     Text format     Abstract available


  84. XIA Y, Li Y, Westover KD, Sun J, et al
    Inhibition of Cell Proliferation in an NRAS Mutant Melanoma Cell Line by Combining Sorafenib and alpha-Mangostin.
    PLoS One. 2016;11:e0155217.
    PubMed     Text format     Abstract available


  85. KESKINOV AA, Tapias V, Watkins SC, Ma Y, et al
    Impact of the Sensory Neurons on Melanoma Growth In Vivo.
    PLoS One. 2016;11:e0156095.
    PubMed     Text format     Abstract available


  86. GUGGER A, Barnhill RL, Seifert B, Dehler S, et al
    Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations.
    PLoS One. 2016;11:e0156115.
    PubMed     Text format     Abstract available


  87. MAEKAWA N, Konnai S, Okagawa T, Nishimori A, et al
    Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma.
    PLoS One. 2016;11:e0157176.
    PubMed     Text format     Abstract available


  88. MARQUES CM, MacNeil S
    Use of a Tissue Engineered Human Skin Model to Investigate the Effects of Wounding and of an Anti-Inflammatory on Melanoma Cell Invasion.
    PLoS One. 2016;11:e0156931.
    PubMed     Text format     Abstract available


  89. NATH K, Nelson DS, Putt ME, Leeper DB, et al
    Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    PLoS One. 2016;11:e0157125.
    PubMed     Text format     Abstract available


  90. TALAR B, Gajos-Michniewicz A, Talar M, Chouaib S, et al
    Pentoxifylline Inhibits WNT Signalling in beta-Cateninhigh Patient-Derived Melanoma Cell Populations.
    PLoS One. 2016;11:e0158275.
    PubMed     Text format     Abstract available


  91. MUN JH, Ohn J, Kim WI, Park SM, et al
    Dermoscopy of Melanomas on the Trunk and Extremities in Asians.
    PLoS One. 2016;11:e0158374.
    PubMed     Text format     Abstract available


  92. HUANG Q, Wei H, Wu Z, Li L, et al
    Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis.
    PLoS One. 2016;11:e0149640.
    PubMed     Text format     Abstract available


  93. GROSSI MARCONI D, da Costa Resende B, Rauber E, de Cassia Soares P, et al
    Head and Neck Non-Melanoma Skin Cancer Treated By Superficial X-Ray Therapy: An Analysis of 1021 Cases.
    PLoS One. 2016;11:e0156544.
    PubMed     Text format     Abstract available


  94. DORAN CM, Ling R, Byrnes J, Crane M, et al
    Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia.
    PLoS One. 2016;11:e0147665.
    PubMed     Text format     Abstract available


  95. KICIELINSKA J, Szczygiel A, Rossowska J, Anger N, et al
    Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models.
    PLoS One. 2016;11:e0148156.
    PubMed     Text format     Abstract available


  96. FROUIN E, Maudelonde T, Senal R, Larrieux M, et al
    Comparative Methods to Improve the Detection of BRAF V600 Mutations in Highly Pigmented Melanoma Specimens.
    PLoS One. 2016;11:e0158698.
    PubMed     Text format     Abstract available


  97. AZZARITO T, Lugini L, Spugnini EP, Canese R, et al
    Effect of Modified Alkaline Supplementation on Syngenic Melanoma Growth in CB57/BL Mice.
    PLoS One. 2016;11:e0159763.
    PubMed     Text format     Abstract available


  98. VEDEL-KROGH S, Nielsen SF, Schnohr P, Nordestgaard BG, et al
    Morbidity and Mortality in 7,684 Women According to Personal Hair Dye Use: The Copenhagen City Heart Study followed for 37 Years.
    PLoS One. 2016;11:e0151636.
    PubMed     Text format     Abstract available


  99. YUAN P, Cao JL, Abuduwufuer A, Wang LM, et al
    Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
    PLoS One. 2016;11:e0146803.
    PubMed     Text format     Abstract available


  100. LIN Z, Chen X, Li Z, Luo Y, et al
    PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0160485.
    PubMed     Text format     Abstract available


  101. LIMM K, Dettmer K, Reinders J, Oefner PJ, et al
    Characterization of the Methylthioadenosine Phosphorylase Polymorphism rs7023954 - Incidence and Effects on Enzymatic Function in Malignant Melanoma.
    PLoS One. 2016;11:e0160348.
    PubMed     Text format     Abstract available


  102. HACKLER L JR, Ozsvari B, Gyuris M, Sipos P, et al
    The Curcumin Analog C-150, Influencing NF-kappaB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo.
    PLoS One. 2016;11:e0149832.
    PubMed     Text format     Abstract available


  103. YAMAMOTO M, Zhao M, Hiroshima Y, Zhang Y, et al
    Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model.
    PLoS One. 2016;11:e0160882.
    PubMed     Text format     Abstract available


  104. MUN JH, Ohn J, Kim WI, Park SM, et al
    Correction: Dermoscopy of Melanomas on the Trunk and Extremities in Asians.
    PLoS One. 2016;11:e0161419.
    PubMed     Text format     Abstract available


  105. ELISIA I, Nakamura H, Lam V, Hofs E, et al
    DMSO Represses Inflammatory Cytokine Production from Human Blood Cells and Reduces Autoimmune Arthritis.
    PLoS One. 2016;11:e0152538.
    PubMed     Text format     Abstract available


  106. LUTZ NW, Banerjee P, Wilson BJ, Ma J, et al
    Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.
    PLoS One. 2016;11:e0161803.
    PubMed     Text format     Abstract available


  107. MALO CS, Renner DN, Huseby Kelcher AM, Jin F, et al
    The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma.
    PLoS One. 2016;11:e0162064.
    PubMed     Text format     Abstract available


  108. DASHTSOODOL N, Shigeura T, Ozawa R, Harada M, et al
    Generation of Novel Traj18-Deficient Mice Lacking Valpha14 Natural Killer T Cells with an Undisturbed T Cell Receptor alpha-Chain Repertoire.
    PLoS One. 2016;11:e0153347.
    PubMed     Text format     Abstract available


  109. ALARI-PAHISSA E, Grandclement C, Jeevan-Raj B, Leclercq G, et al
    Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition.
    PLoS One. 2016;11:e0153236.
    PubMed     Text format     Abstract available


  110. WU L, Hu Z, Huang Y, Yu Y, et al
    Radiation Changes the Metabolic Profiling of Melanoma Cell Line B16.
    PLoS One. 2016;11:e0162917.
    PubMed     Text format     Abstract available


  111. JIANG F, Jin K, Huang S, Bao Q, et al
    Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells.
    PLoS One. 2016;11:e0159849.
    PubMed     Text format     Abstract available


  112. LE TT, Skak K, Schroder K, Schroder WA, et al
    IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate.
    PLoS One. 2016;11:e0153975.
    PubMed     Text format     Abstract available


  113. GONZALES C, Yoshihara HA, Dilek N, Leignadier J, et al
    In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by 19F-Fluorine MRS/MRI.
    PLoS One. 2016;11:e0164557.
    PubMed     Text format     Abstract available


  114. VAN ESSEN TH, van Pelt SI, Bronkhorst IH, Versluis M, et al
    Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.
    PLoS One. 2016;11:e0164292.
    PubMed     Text format     Abstract available


  115. MISHRA PJ, Mishra PJ, Merlino G
    Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.
    PLoS One. 2016;11:e0165102.
    PubMed     Text format     Abstract available


  116. YU J, Luo X, Huang H, Zhai Z, et al
    Clinical Characteristics of Malignant Melanoma in Southwest China: A Single-Center Series of 82 Consecutive Cases and a Meta-Analysis of 958 Reported Cases.
    PLoS One. 2016;11:e0165591.
    PubMed     Text format     Abstract available


  117. RODOLFO C, Rocco M, Cattaneo L, Tartaglia M, et al
    Ophiobolin A Induces Autophagy and Activates the Mitochondrial Pathway of Apoptosis in Human Melanoma Cells.
    PLoS One. 2016;11:e0167672.
    PubMed     Text format     Abstract available


  118. TOBIO A, Alfonso A, Madera-Salcedo I, Botana LM, et al
    Yessotoxin, a Marine Toxin, Exhibits Anti-Allergic and Anti-Tumoural Activities Inhibiting Melanoma Tumour Growth in a Preclinical Model.
    PLoS One. 2016;11:e0167572.
    PubMed     Text format     Abstract available


  119. KOMINA A, Palkina N, Aksenenko M, Tsyrenzhapova S, et al
    Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.
    PLoS One. 2016;11:e0168229.
    PubMed     Text format     Abstract available


    January 2015
  120. ROSSI AH, Farias A, Fernandez JE, Bonomi HR, et al
    Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.
    PLoS One. 2015;10:e0126827.
    PubMed     Text format     Abstract available


  121. WYATT C, Lucas RM, Hurst C, Kimlin MG, et al
    Vitamin d deficiency at melanoma diagnosis is associated with higher breslow thickness.
    PLoS One. 2015;10:e0126394.
    PubMed     Text format     Abstract available


  122. SUN L, Bian G, Meng Z, Dang G, et al
    MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.
    PLoS One. 2015;10:e0124428.
    PubMed     Text format     Abstract available


  123. KINIWA Y, Li J, Wang M, Sun C, et al
    Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4+ Th1 Cells.
    PLoS One. 2015;10:e0124094.
    PubMed     Text format     Abstract available


  124. MORIARTY JP, Borah BJ, Foote RL, Pulido JS, et al
    Cost-effectiveness of proton beam therapy for intraocular melanoma.
    PLoS One. 2015;10:e0127814.
    PubMed     Text format     Abstract available


  125. RADAELLI E, Hermans E, Omodho L, Francis A, et al
    Spontaneous Post-Transplant Disorders in NOD.Cg- Prkdcscid Il2rgtm1Sug/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas.
    PLoS One. 2015;10:e0124974.
    PubMed     Text format     Abstract available


  126. HARTMAN ML, Talar B, Gajos-Michniewicz A, Czyz M, et al
    MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment.
    PLoS One. 2015;10:e0128796.
    PubMed     Text format     Abstract available


  127. VAMAN V S A, Poppe H, Houben R, Grunewald TG, et al
    LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression.
    PLoS One. 2015;10:e0129219.
    PubMed     Text format     Abstract available


  128. PAOLONI M, Mazcko C, Selting K, Lana S, et al
    Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma.
    PLoS One. 2015;10:e0129954.
    PubMed     Text format     Abstract available


  129. CARBOGNIN L, Pilotto S, Milella M, Vaccaro V, et al
    Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
    PLoS One. 2015;10:e0130142.
    PubMed     Text format     Abstract available


  130. FUKUDA K, Sugihara E, Ohta S, Izuhara K, et al
    Periostin Is a Key Niche Component for Wound Metastasis of Melanoma.
    PLoS One. 2015;10:e0129704.
    PubMed     Text format     Abstract available


  131. SHEN J, Gopalakrishnan V, Lee JE, Fang S, et al
    Mitochondrial DNA Copy Number in Peripheral Blood and Melanoma Risk.
    PLoS One. 2015;10:e0131649.
    PubMed     Text format     Abstract available


  132. RAFIQ RA, Quadri A, Nazir LA, Peerzada K, et al
    A Potent Inhibitor of Phosphoinositide 3-Kinase (PI3K) and Mitogen Activated Protein (MAP) Kinase Signalling, Quercetin (3, 3', 4', 5, 7-Pentahydroxyflavone) Promotes Cell Death in Ultraviolet (UV)-B-Irradiated B16F10 Melanoma Cells.
    PLoS One. 2015;10:e0131253.
    PubMed     Text format     Abstract available


  133. CATTANEO L, Cicconi R, Mignogna G, Giorgi A, et al
    Anti-Proliferative Effect of Rosmarinus officinalis L. Extract on Human Melanoma A375 Cells.
    PLoS One. 2015;10:e0132439.
    PubMed     Text format     Abstract available


  134. SHAO Z, Bao Q, Jiang F, Qian H, et al
    VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo.
    PLoS One. 2015;10:e0132655.
    PubMed     Text format     Abstract available


  135. TARHINI AA, Lin Y, Zahoor H, Shuai Y, et al
    Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-alpha but Not Observation in Intermediate Risk Melanoma Patients.
    PLoS One. 2015;10:e0132745.
    PubMed     Text format     Abstract available


  136. MARZAGALLI M, Casati L, Moretti RM, Montagnani Marelli M, et al
    Estrogen Receptor beta Agonists Differentially Affect the Growth of Human Melanoma Cell Lines.
    PLoS One. 2015;10:e0134396.
    PubMed     Text format     Abstract available


  137. MESSAOUDENE M, Perier A, Fregni G, Neves E, et al
    Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.
    PLoS One. 2015;10:e0133363.
    PubMed     Text format     Abstract available


  138. SALVATIERRA E, Alvarez MJ, Leishman CC, Rivas Baquero E, et al
    SPARC Controls Melanoma Cell Plasticity through Rac1.
    PLoS One. 2015;10:e0134714.
    PubMed     Text format     Abstract available


  139. CLAWSON GA, Matters GL, Xin P, Imamura-Kawasawa Y, et al
    Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients.
    PLoS One. 2015;10:e0134320.
    PubMed     Text format     Abstract available


  140. BHANDARU M, Martinka M, McElwee KJ, Rotte A, et al
    Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.
    PLoS One. 2015;10:e0134678.
    PubMed     Text format     Abstract available


  141. CRABB JW, Hu B, Crabb JS, Triozzi P, et al
    iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.
    PLoS One. 2015;10:e0135543.
    PubMed     Text format     Abstract available


  142. FISCHBECK S, Imruck BH, Blettner M, Weyer V, et al
    Psychosocial Care Needs of Melanoma Survivors: Are They Being Met?
    PLoS One. 2015;10:e0132754.
    PubMed     Text format     Abstract available


  143. HALDER B, Singh S, Thakur SS
    Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells.
    PLoS One. 2015;10:e0137498.
    PubMed     Text format     Abstract available


  144. MARKOV OV, Mironova NL, Sennikov SV, Vlassov VV, et al
    Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.
    PLoS One. 2015;10:e0136911.
    PubMed     Text format     Abstract available


  145. DE LANGE MJ, Razzaq L, Versluis M, Verlinde S, et al
    Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.
    PLoS One. 2015;10:e0138002.
    PubMed     Text format     Abstract available


  146. MANGANA J, Cheng PF, Schindler K, Weide B, et al
    Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
    PLoS One. 2015;10:e0139438.
    PubMed     Text format     Abstract available


  147. CAPALDO BJ, Roller D, Axelrod MJ, Koeppel AF, et al
    Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma.
    PLoS One. 2015;10:e0138210.
    PubMed     Text format     Abstract available


  148. SPIESBERGER K, Paulfranz F, Egger A, Reiser J, et al
    Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle.
    PLoS One. 2015;10:e0140471.
    PubMed     Text format     Abstract available


  149. FRIEDMAN AA, Amzallag A, Pruteanu-Malinici I, Baniya S, et al
    Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
    PLoS One. 2015;10:e0140310.
    PubMed     Text format     Abstract available


  150. GALVAN DL, O'Neil RT, Foster AE, Huye L, et al
    Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model.
    PLoS One. 2015;10:e0140744.
    PubMed     Text format     Abstract available


  151. CARON JM, Caron JM
    Methyl Sulfone Blocked Multiple Hypoxia- and Non-Hypoxia-Induced Metastatic Targets in Breast Cancer Cells and Melanoma Cells.
    PLoS One. 2015;10:e0141565.
    PubMed     Text format     Abstract available


  152. HALDER B, Singh S, Thakur SS
    Correction: Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells.
    PLoS One. 2015;10:e0141053.
    PubMed     Text format     Abstract available


  153. SHAO H, Kong R, Ferrari ML, Radtke F, et al
    Notch1 Pathway Activity Determines the Regulatory Role of Cancer-Associated Fibroblasts in Melanoma Growth and Invasion.
    PLoS One. 2015;10:e0142815.
    PubMed     Text format     Abstract available


  154. STADLER J, Eder J, Pratscher B, Brandt S, et al
    SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.
    PLoS One. 2015;10:e0142273.
    PubMed     Text format     Abstract available


  155. KAUSHIK A, Bhatia Y, Ali S, Gupta D, et al
    Gene Network Rewiring to Study Melanoma Stage Progression and Elements Essential for Driving Melanoma.
    PLoS One. 2015;10:e0142443.
    PubMed     Text format     Abstract available


  156. PYATNITSKIY M, Karpov D, Poverennaya E, Lisitsa A, et al
    Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma.
    PLoS One. 2015;10:e0142819.
    PubMed     Text format     Abstract available


  157. KUMAGAI K, Tabu K, Sasaki F, Takami Y, et al
    Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
    PLoS One. 2015;10:e0143413.
    PubMed     Text format     Abstract available


  158. LIU YM, Li Y, Wei WB, Xu X, et al
    Clinical Characteristics of 582 Patients with Uveal Melanoma in China.
    PLoS One. 2015;10:e0144562.
    PubMed     Text format     Abstract available


  159. MIYASHITA A, Fukushima S, Nakahara S, Yamashita J, et al
    Investigation of FOXM1 as a Potential New Target for Melanoma.
    PLoS One. 2015;10:e0144241.
    PubMed     Text format     Abstract available


  160. LARKIN J, Hatswell AJ, Nathan P, Lebmeier M, et al
    The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK.
    PLoS One. 2015;10:e0145524.
    PubMed     Text format     Abstract available


  161. SCHARTL M, Shen Y, Maurus K, Walter R, et al
    Whole Body Melanoma Transcriptome Response in Medaka.
    PLoS One. 2015;10:e0143057.
    PubMed     Text format     Abstract available


  162. UZANA R, Eisenberg G, Merims S, Frankenburg S, et al
    Human T cell crosstalk is induced by tumor membrane transfer.
    PLoS One. 2015;10:e0118244.
    PubMed     Text format     Abstract available


  163. LHOUMEAU AC, Martinez S, Boher JM, Monges G, et al
    Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
    PLoS One. 2015;10:e0123768.
    PubMed     Text format     Abstract available


  164. MARTEL G, Hawel J, Rekman J, Croome KP, et al
    Liver resection for non-colorectal, non-carcinoid, non-sarcoma metastases: a multicenter study.
    PLoS One. 2015;10:e0120569.
    PubMed     Text format     Abstract available


  165. CHRISTOPHE C, Muller S, Rodrigues M, Petit AE, et al
    A biased competition theory of cytotoxic T lymphocyte interaction with tumor nodules.
    PLoS One. 2015;10:e0120053.
    PubMed     Text format     Abstract available


  166. KRIZBAI IA, Gasparics A, Nagyoszi P, Fazakas C, et al
    Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation.
    PLoS One. 2015;10:e0123845.
    PubMed     Text format     Abstract available


  167. KOLLGAARD T, Ugurel-Becker S, Idorn M, Andersen MH, et al
    Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes.
    PLoS One. 2015;10:e0131934.
    PubMed     Text format     Abstract available


  168. BEIDERWELLEN K, Geraldo L, Ruhlmann V, Heusch P, et al
    Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.
    PLoS One. 2015;10:e0137285.
    PubMed     Text format     Abstract available


    January 2014
  169. DA SILVA PC, Rosembach TV, Santos AA, Rocha MS, et al
    Normal and tumoral melanocytes exhibit q-Gaussian random search patterns.
    PLoS One. 2014;9:e104253.
    PubMed     Text format     Abstract available


  170. CHEN SC, Su YC, Lu YT, Ko PC, et al
    Defects in the Acquisition of Tumor-Killing Capability of CD8+ Cytotoxic T Cells in Streptozotocin-Induced Diabetic Mice.
    PLoS One. 2014;9:e109961.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: